Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs
Financial updatesCosts for conversion of Ordinary Shares into ADS’s waived by JP Morgan Chase for initial four weeks after today
Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR”
Financial updatesPharming Group announces that, effective today, its American Depositary Shares (“ADSs”) have been admitted for listing on the Nasdaq Global Market (“Nasdaq”) under the symbol “PHAR” and will begin trading tomorrow; Wednesday 23 December. Each ADS represents 10 of the Company’s ordinary shares of €0.01 nominal value (“Ordinary Shares”).
Pharming Reports on Extraordinary General Meeting of Shareholders
Financial updatesPharming Group N.V. announces that at its Extraordinary General Meeting of shareholders (EGM), held today, all proposals were approved. As a result, the one-tier board structure has become effective, and Barbara Yanni and Mark Pykett have been appointed as non-executive board members.
Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ordinary Shares on Nasdaq Global Market
Financial updatesPharming Group N.V., a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs, today announces that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (the "SEC") in connection with a proposed listing of American Depositary Shares ("ADSs") representing the Company's ordinary shares of nominal value €0.01 each ("Ordinary Shares") on the Nasdaq Global Market ("Nasdaq").
Pharming convenes Extraordinary General Meeting of shareholders
Financial updatesPharming Group N.V. announces it will hold an Extraordinary General Meeting (EGM) of Shareholders on Friday 11 December 2020 at 14:00 CET.
Pharming Group reports financial results for the first nine months of 2020
Financial updatesPharming Group N.V. presents its (unaudited) financial report for the nine months and third quarter ended 30 September 2020.
Pharming Group reports financial results for the first half of 2020
Financial updatesPharming Group N.V. presents its (unaudited) financial report for the six months ended 30 June 2020.
Pharming Reports on Annual General Meeting of Shareholders
Financial updatesPharming Group N.V. announces that at its Annual General Meeting of shareholders (AGM), held today, the proposals related to remuneration were withdrawn and all other proposals were approved.
Pharming Group reports financial results for the first quarter of 2020
Financial updatesPharming Group N.V. presents its (unaudited) financial report for the first quarter of the year ended 31 March 2020.
Pharming Group convenes Annual General Meeting of Shareholders
Financial updatesPharming Group N.V. invites its shareholders to the 2020 Annual General Meeting (AGM) to be held at 14:00 CET on 20 May 2020